Case Report: Upadacitinib and apremilast combination therapy for guselkumab-induced paradoxical eczema in psoriasis.
Saved in:
| Title: | Case Report: Upadacitinib and apremilast combination therapy for guselkumab-induced paradoxical eczema in psoriasis. |
|---|---|
| Authors: | Yang L; Department of Dermatology, Jinan Dermatosis Prevention and Control Hospital, Jinan, Shandong, China., Zhou J; Department of Dermatology, Jinan Dermatosis Prevention and Control Hospital, Jinan, Shandong, China., Ruan Z; Department of Dermatology, Jinan Dermatosis Prevention and Control Hospital, Jinan, Shandong, China., Shi K; Department of Dermatology, Jinan Dermatosis Prevention and Control Hospital, Jinan, Shandong, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Apr 17; Vol. 17, pp. 1696255. Date of Electronic Publication: 2026 Apr 17 (Print Publication: 2026). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1696255 |
